An Open-label, Crossover, Interventional Phase IV Study to Compare the Ease of Use of TIP With Nebulized TIS and Nebulized COLI for the Treatment of Pulmonary Pseudomonas Aeruginosa (P.a) in Patients With Cystic Fibrosis

Trial Profile

An Open-label, Crossover, Interventional Phase IV Study to Compare the Ease of Use of TIP With Nebulized TIS and Nebulized COLI for the Treatment of Pulmonary Pseudomonas Aeruginosa (P.a) in Patients With Cystic Fibrosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Jul 2016

At a glance

  • Drugs Tobramycin (Primary) ; Colistimethate sodium; Tobramycin
  • Indications Cystic fibrosis; Pseudomonal infections
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 05 Dec 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
    • 04 Nov 2014 Planned End Date changed from 1 Dec 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
    • 04 Nov 2014 Planned primary completion date changed from 1 Dec 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top